Sidebar Ads

Sunday, January 6, 2019

Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene


Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene



If this proposed acquisition was a game show, it would be called "The Price Isn't Right."

Related Posts:

0 comments:

Post a Comment

What will be in the chancellor's Spring Statement?

Chancellor Rachel Reeves will give more detail about the government's plans for the economy. from BBC News https://ift.tt/GkI7Cuc